Abstract: The present invention is related to a method for preparing VIB Group metal oxide particles or dispersions, wherein the VIB Group metal is tungsten or molybdenum. The methods include: 1) providing precursors of VIB Group metal oxide, reductants and supercritical fluids. 2) said VIB Group metal oxide particles, or dispersions are obtained by the reaction between said metal oxide precursors, and reductants are under supercritical state in said supercritical fluids. Especially, said VIB Group metal oxide can be tungsten bronze, molybdenum bronze, or tungsten and molybdenum bronze which can be present by the formula AxByMOz. Wherein, A represents element exists in the form of dopant cation; and B represents element exists in the form of dopant anion; O represents oxygen; 0?x?1, 0?y?1, 0<x+y?1, and 2?z?3.

Abstract: The present invention is related to a method for preparing VIB Group metal oxide particles or dispersions, wherein the VIB Group metal is tungsten or molybdenum. The methods include: 1) providing precursors of VIB Group metal oxide, reductants and supercritical fluids. 2) said VIB Group metal oxide particles, or dispersions are obtained by the reaction between said metal oxide precursors, and reductants are under supercritical state in said supercritical fluids. Especially, said VIB Group metal oxide can be tungsten bronze, molybdenum bronze, or tungsten and molybdenum bronze which can be present by the formula AxByMOz. Wherein, A represents element exists in the form of dopant cation; and B represents element exists in the form of dopant anion; O represents oxygen; 0?x?1, 0?y?1, 0<x+y?1, and 2?z?3.

Abstract: A process for making particles for delivery of drug nanoparticles is disclosed herein. The process comprises the steps of (a) forming a suspension of drug nanoparticles by mixing a precipitant solution with an anti-solvent solution under micro-mixing environment, where the formed nanoparticles have a narrow particle size distribution; (b) providing an excipient to at least one of the precipitant solution, the anti-solvent solution and the suspension of drug nanoparticles, the excipient being selected to maintain said drug nanoparticles in a dispersed state when in liquid form; and (c) drying the suspension of drug nanoparticles containing the excipient therein to remove solvent therefrom, wherein removal of the solvent causes the excipient to solidify and thereby form micro-sized matrix particles, each micro-sized particle being comprised of drug nanoparticles dispersed in a solid matrix of the excipient.

Abstract: A process for making particles for delivery of drug nanoparticles is disclosed herein. The process comprises the steps of (a) forming a suspension of drug nanoparticles by mixing a precipitant solution with an anti-solvent solution under micro-mixing environment, where the formed nanoparticles have a narrow particle size distribution; (b) providing an excipient to at least one of the precipitant solution, the anti-solvent solution and the suspension of drug nanoparticles, the excipient being selected to maintain said drug nanoparticles in a dispersed state when in liquid form; and (c) drying the suspension of drug nanoparticles containing the excipient therein to remove solvent therefrom, wherein removal of the solvent causes the excipient to solidify and thereby form micro-sized matrix particles, each micro-sized particle being comprised of drug nanoparticles dispersed in a solid matrix of the excipient.

Abstract: There is disclosed a process of making nano-sized or micro-sized precipitate particles. The process comprising the steps of mixing, in a reaction zone, a metal salt solution with a precipitant solution to form a precipitate, said precipitate being at least one of a metal chalcogenide, metal hydroxide and metal oxide; and applying a shear force to said mixing solutions in said reaction zone during said mixing step, wherein said shear force and the conditions within said reaction zone form said nano-sized or micro-sized precipitate particles.

Abstract: There is disclosed a process of making nano-sized or micro-sized precipitate particles. The process comprising the steps of mixing, in a reaction zone, a metal salt solution with a precipitant solution to form a precipitate, said precipitate being at least one of a metal chalcogenide, metal hydroxide and metal oxide; and applying a shear force to said mixing solutions in said reaction zone during said mixing step, wherein said shear force and the conditions within said reaction zone form said nano-sized or micro-sized precipitate particles.

Abstract: A process for preparation of particles of an inhalable drug is described. The process comprises combining a first liquid and a second liquid in a region of high shear, whereby the first liquid and the second liquid interact to form the particles of the drug. One of the first and second liquids comprises the drug or a precursor thereof. In the case where one of the liquids comprises the precursor, the other of the first and second liquids comprises a reagent which reacts with the precursor under high shear conditions to form particles of the drug. In the case where one of the liquids comprises the drug, the other of the first and second liquids comprises a liquid which, when mixed with the liquid containing the drug under high shear, forms particles of the drug.

Abstract: A process of making dispersant-coated carbon particles comprising the steps of providing a liquid mixture comprising carbon particles and a dispersant, and imparting a shear force to the liquid mixture to thereby form said dispersant-coated carbon particles.